|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2003-12-01 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1995-10-20 |
|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1975-04-18 |
Safety Study of Bintrafusp alfa in Combination with Other Anti-cancer Therapies in Participants with Locally Advanced or Advanced Cervical Cancer
Safety Study of Bintrafusp alfa in Combination with Other Anti-cancer Therapies in Participants with Locally Advanced or Advanced Cervical Cancer
A Phase II Multicenter Randomized Open-Label Controlled Study of M7824 Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer
100 项与 Merck Biopharma Co., Ltd. 相关的临床结果
0 项与 Merck Biopharma Co., Ltd. 相关的专利(医药)
100 项与 Merck Biopharma Co., Ltd. 相关的药物交易
100 项与 Merck Biopharma Co., Ltd. 相关的转化医学